1. **Kill shot.**  
The paper’s headline claim in the Abstract and §4(3) that Qwen hidden thinking and trace replay are “statistically indistinguishable” (Table 2, B−C OR=0.99, p_adj=.899) is not identified. Per §2.7/§3.4, you only reran the 367/1030 Qwen-B cases selected by a post-treatment outcome (8K ceiling hit), then replaced those rows in a merged dataset; per RUN_MANIFEST, those replacements are also under a different Ollama version (0.20.6 vs 0.20.2 for the untouched rows), and no same-build full-cohort rerun was done. That condition-specific, outcome-conditioned replacement can mechanically erase B−C. Since this is the central mechanistic conclusion, rejection is warranted unless you rerun full B and C cohorts under one frozen stack.

2. **Critical flaws** (CRITICAL — publication-blocking).
1. **Post-treatment selective rerun invalidates the key causal contrast.**  
   Evidence: §2.7, §3.4, Table 2 (Qwen B−C flips from significant at 8K to null after merged rerun), RUN_MANIFEST cross-version heterogeneity note.  
   Why blocking: Main claim depends on non-random row replacement in one arm only.
2. **Core mechanism controls are acknowledged as not faithful to their intended interventions.**  
   Evidence: §7 “Protocol-fidelity issues… not closed”: legacy token count mismatch (~1.79x) affecting G/J, Condition I hardcoded `mean_a_tokens=50` giving wrong `k`, and F shuffle decoding artifacts.  
   Why blocking: These directly contaminate C−F, G−F, C−J, B−I, which are central in §4 robust claims.
3. **Reproducibility provenance is incomplete at inference level.**  
   Evidence: RUN_MANIFEST: per-inference `model_digest` blank in all logs; generation options not logged per inference; `gemma4:latest` mutable tag; digests captured after collection.  
   Why blocking: Exact replication is not possible for a paper making strong reproducibility claims.
4. **Inference validity is fragile for the claimed certainty.**  
   Evidence: §7 admits 103 clusters with no small-cluster GEE correction; Table 3 has separation (`→∞`, `→0` ORs); multiplicity handling is partial vs many reported contrasts.  
   Why blocking: p-values supporting “robust claims” are not trustworthy enough for top-tier acceptance.

3. **Important flaws** (IMPORTANT — major revision required).
1. **Equivalence is claimed from non-significance.** §1 defines SESOI (OR 0.85–1.18), but §4(3) relies on p>.05 instead of a formal equivalence test.
2. **Estimand mixing remains problematic.** §3.3 uses conditional-on-extraction analyses (post-treatment subset) for mechanistic interpretation; collider risk remains.
3. **Question-set selection risks analytic drift/cherry-picking.** §2.2 selects from 740 based on model performance; realized A accuracy jumps to ~83%, undermining calibration intent.
4. **Phase 3 interpretation is weakly identified.** §3.5–§3.7 rely on historical controls across software versions (RUN_MANIFEST).

4. **Minor flaws** (MINOR — polish).
1. Table/reporting clarity is uneven (e.g., merged-dataset ceiling-rate interpretation is hard to reconcile across §3.1 vs §3.4).  
2. Effect-size communication is OR-heavy despite high baselines; risk differences would improve interpretability.  
3. No domain-stratified results despite four-domain framing.

5. **What the authors do right.**  
The manuscript is unusually transparent about limitations, post-hoc decisions, and provenance gaps; it releases logs/code and does attempt principled within-model contrasts plus hurdle decomposition rather than relying on a single headline metric.

6. **Recommendation.**  
**Reject.** The central conclusion rests on a post-treatment, condition-specific rerun with stack heterogeneity, and multiple key control manipulations are explicitly unresolved, so the causal claims are not publication-grade.